Description
Despite advances in technology, cardiovascular disease (CVD) remains the leading cause of death, disability, and healthcare costs in the U.S. Yet, there is a tremendous gap in accurate cardiovascular risk prediction and prevention, particularly in racial/ethnic minorities.
The overall goal of this study is to address gaps in knowledge about CVD prediction and treatment in understudied racial/ethnic minority populations. The study will utilize the electronic health record data from the CASPER study, an established NHLBI-funded cohort enriched with disaggregated Hispanic and Asian patients.
PI is Fatima Rodriguez, M.D., MPH, Division of Cardiovascular Medicine, Department of Medicine, Stanford University. Research Scientist Development Award (K01).
Site PI is Jiang Li, Ph.D.
Principal Investigator
Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Funder
National Institute of Health National Heart, Lung, and Blood Institute, Robert Wood Johnson Foundation/American Heart Association Faculty Development Award Program
Start Date
February 01, 2019
End Date
January 31, 2024
Related Studies
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH, Cheryl Stults, Ph.D.
COVID-19 Universal Registry for Vital Evaluations (CURVE) Project
Investigators: Robert Romanelli, Ph.D., MPH, Jiang Li, Ph.D., MPH
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigators: Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D., Su-Ying Liang, Ph.D.
Pilot Project in Applied Artificial Intelligence: Using Machine Learning to Improve the Safety of Hospital Care
Investigators: Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Randomized study of EHR Defaults and Using social Comparison feedback to effectively decrease opioid prescription pill burden (REDUCE).
Investigator: Xiaowei (Sherry) Yan, PhD, MS
Stupski Serious Illness Program Evaluation
Investigators: Sylvia Sudat, PhD, Ellis C. Dillon, Ph.D.
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS